Copyright
©The Author(s) 2020.
World J Clin Cases. Oct 6, 2020; 8(19): 4527-4534
Published online Oct 6, 2020. doi: 10.12998/wjcc.v8.i19.4527
Published online Oct 6, 2020. doi: 10.12998/wjcc.v8.i19.4527
Figure 3 Levels of serum inflammatory parameters after initiation of tofacitinib treatment.
IL: Interleukin; TNF: Tumor necrosis factor.
- Citation: Li B, Li GW, Xue L, Chen YY. Rapid remission of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome in response to the Janus kinase inhibitor tofacitinib: A case report. World J Clin Cases 2020; 8(19): 4527-4534
- URL: https://www.wjgnet.com/2307-8960/full/v8/i19/4527.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i19.4527